Incyte Corp.

NASDAQ:INCY  
68.45
+0.28 (+0.41%)
4:06:22 PM EDT: $66.00 -2.45 (-3.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)13.30B
Current PE625.49
Forward PE 12.07
2yr Forward PE 10.19
See more stats
Estimates Current Quarter
Revenue$1.15 Billion
Adjusted EPS$1.40
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Incyte Corp. Stock, NASDAQ:INCY

1801 Augustine Cut-Off, 1801 Augustine Cut-Off, Wilmington, Delaware 19803
United States of America
Phone: +1.302.498.6700
Number of Employees: 2617

Description

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.